P M Hellström Selected Research

ulimorelin

3/2011	Randomised clinical trial: ghrelin agonist TZP-101 relieves gastroparesis associated with severe nausea and vomiting--randomised clinical study subset data.
10/2010	Safety and efficacy of ghrelin agonist TZP-101 in relieving symptoms in patients with diabetic gastroparesis: a randomized, placebo-controlled study.
6/2009	Ghrelin receptor agonist (TZP-101) accelerates gastric emptying in adults with diabetes and symptomatic gastroparesis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P M Hellström Research Topics

Disease

7	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 02/2013 - 05/2001
6	Gastroparesis 02/2013 - 09/2006
6	Type 2 Diabetes Mellitus (MODY) 01/2011 - 07/2001
5	Weight Loss (Weight Reduction) 07/2011 - 10/2000
4	Insulin Resistance 05/2018 - 10/2000
4	Colitis 02/2013 - 08/2006
4	Irritable Bowel Syndrome (Syndrome, Irritable Bowel) 11/2012 - 06/2008
4	Crohn Disease (Crohn's Disease) 04/2007 - 10/2001
3	Inflammation (Inflammations) 02/2013 - 04/2007
3	Ulcerative Colitis 10/2010 - 10/2001
2	Neoplasms (Cancer) 01/2023 - 06/2004
2	Acute Pain 11/2012 - 01/2009
2	Obesity 07/2011 - 01/2009
2	Vomiting 03/2011 - 10/2010
2	Pain (Aches) 01/2011 - 01/2009
1	Mucositis 01/2023
1	Ileus 06/2013
1	Body Weight (Weight, Body) 02/2013
1	Hemorrhage 02/2013
1	Short Bowel Syndrome 01/2013
1	Nausea 03/2011
1	Movement Disorders (Movement Disorder) 06/2009
1	Hyperglycemia 03/2009
1	Gastric Fistula 01/2009
1	Pulmonary Embolism 06/2004
1	Lymphoma (Lymphomas) 06/2004
1	Collagenous Colitis 01/2004
1	Pyoderma Gangrenosum 09/2002
1	Pneumonia (Pneumonitis) 09/2002
1	Exanthema (Rash) 09/2002
1	Skin Manifestations 09/2002
1	Bile Reflux 07/2002
1	Overweight 09/2001
1	Myotonic Dystrophy (Dystrophia Myotonica) 07/2001

Drug/Important Bio-Agent (IBA)

10	Glucagon-Like Peptide 1 (GLP 1)IBA 11/2012 - 07/2001
7	GhrelinIBA 06/2013 - 09/2006
6	Ghrelin ReceptorsIBA 06/2013 - 01/2009
4	IncretinsIBA 07/2011 - 03/2009
4	Infliximab (Remicade)FDA Link 10/2010 - 09/2002
4	Nitric Oxide (Nitrogen Monoxide)FDA Link 04/2007 - 10/2001
3	Insulin (Novolin)FDA Link 05/2018 - 03/2009
3	goblet cell silencer inhibitorIBA 02/2013 - 10/2010
3	valyl(10)- glucagon-like peptide (7-37)IBA 11/2012 - 01/2009
3	Hormones (Hormone)IBA 07/2011 - 07/2001
3	ulimorelinIBA 03/2011 - 06/2009
2	Glucagon (Glukagon)FDA Link 01/2013 - 01/2011
2	Peptides (Polypeptides)IBA 07/2011 - 01/2009
2	Glucose (Dextrose)FDA LinkGeneric 07/2011 - 01/2011
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2007 - 09/2002
2	Nitric Oxide Synthase (NO Synthase)IBA 08/2006 - 01/2004
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	CarbohydratesIBA 05/2018
1	IntegrinsIBA 02/2013
1	AntibodiesIBA 02/2013
1	Azathioprine (Imuran)FDA LinkGeneric 02/2013
1	Dextrans (Dextran)FDA Link 02/2013
1	Methotrexate (Mexate)FDA LinkGeneric 02/2013
1	SodiumIBA 02/2013
1	Blocking AntibodiesIBA 02/2013
1	Mesalamine (Mesalazine)FDA LinkGeneric 02/2013
1	Therapeutic UsesIBA 02/2013
1	Glucagon-Like Peptides (Enteroglucagon)IBA 07/2011
1	OxyntomodulinIBA 07/2011
1	Glucagon-Like Peptide-1 Receptor AgonistsIBA 01/2011
1	Exenatide (Byetta)FDA Link 01/2011
1	Parasympatholytics (Antispasmodics)IBA 01/2011
1	SteroidsIBA 10/2010
1	Serotonin (5 Hydroxytryptamine)IBA 06/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2009
1	Metoclopramide (Reglan)FDA LinkGeneric 06/2009
1	Erythromycin (Erycette)FDA LinkGeneric 06/2009
1	AcidsIBA 01/2009
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 01/2009
1	Hydrochloric Acid (Hydrogen Chloride)FDA Link 01/2009
1	Interferon-gamma (Interferon, gamma)IBA 04/2007
1	Interleukin-1beta (Interleukin 1 beta)IBA 04/2007
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 04/2007
1	Monoclonal AntibodiesIBA 04/2007
1	Biomarkers (Surrogate Marker)IBA 04/2007
1	Escherichia coli endotoxinIBA 08/2006
1	EnzymesIBA 08/2006
1	Messenger RNA (mRNA)IBA 08/2006
1	GW002 peptideIBA 03/2004
1	omega-N-Methylarginine (NG Monomethyl L Arginine)IBA 01/2004
1	BilirubinIBA 07/2002
1	Phenobarbital (Luminal)FDA Link 10/2001
1	Neuropeptide YIBA 10/2000
1	MotilinIBA 10/2000

Therapy/Procedure

4	Therapeutics 01/2023 - 06/2009
2	Colectomy 10/2010 - 06/2004
1	Drug Therapy (Chemotherapy) 01/2023
1	Lasers (Laser) 01/2013
1	Jejunostomy 01/2013
1	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2011
1	Injections 01/2011
1	Aftercare (After-Treatment) 01/2009
1	Carbohydrate Loading Diet 08/2008
1	Subcutaneous Infusions 03/2004
1	Subcutaneous Injections 03/2004
1	Baths 05/2001